跳至主要内容
临床试验/NCT04554641
NCT04554641已完成不适用

The Effect of a Multi-strain Live Bacteria Supplement on the Gut Microbiota Composition of Healthy Adults: an Open Label Trial

The Functional Gut Clinic2 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2019年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
48
试验地点
2
主要终点
Stool sample comparison

研究概览

简要总结

Over recent years there has been a lot of research looking at how the bacteria in our gut affect our health. Changes to gut bacteria has been linked to several diseases. Taking specific live bacteria supplements (sometimes known as 'probiotics'), to change the balance of our gut bacteria to result in a health benefit have been trialled as a treatment option for many diseases in recent years.

Bio-Kult Advanced is a live bacteria Food supplement that contains 14 different bacteria cultures. The effect of Bio-Kult Advanced on gut bacteria is unknown, therefore, the aim

详细描述

There is rapidly growing interest in the involvement of the microbiome in health. Imbalance in human gut microbiota, 'dysbiosis', has been linked to several diseases. Manipulation of the microbiome, using specific strains of live micro-organisms, that confer a health benefit on the host (probiotics), have therefore become an exploratory treatment option in microbiome-associated diseases in recent years. Numerous studies have shown selected strains of bacteria to show statistically significant and clinically relevant improvement in symptoms, in a number of diseases, including but not limited to infantile colic and atopic dermatitis.

Bio-Kult Advanced (BKA) is a 14 strain live bacteria supplement containing a Minimum 2 billion live microorganisms per capsule (2x109 CFU/capsule), equivalent to 10 billion live microorganisms per gram (1x1010 CFU/gram). A randomised controlled trial of Bio-Kult Advanced in the management of diarrhoea predominant IBS demonstrated significant improvement in gastrointestinal (GI) symptoms and was well tolerated by participants. Another randomised controlled trial of Bio-Kult Advanced, in participants with episodic and chronic migraine sufferers, demonstrated significant improvement in frequency and severity of migraines compared to placebo. This clinical effectiveness across various conditions, suggest that bacterial strains in Bio-Kult could have an effect on the gastrointestinal flora, however data has yet to be collected that explores the effect of Bio-Kult on the microbiome. The aim of this study is to therefore investigate the effect of Bio-Kult Advanced, on the composition of the gut microbiota in healthy adults.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Adult males and females (50:50) between 18 to 40 years old
  • No significant medical diagnosis (healthy individuals)
  • Not on regular prescription medicines
  • No selective/restricted diets (e.g. vegan, low FODMAP)
  • Body Mass Index of 18.50-29.99 kg/m2
  • Participant able to understand the participant information sheet in English and provide informed consent

排除标准

  • Diagnosis of any medical condition, except for visual impairment and other conditions to clinicians discretion
  • Prior abdominal surgery (e.g. appendectomy, bariatric surgery )
  • Migraine as based on migraine definition by ICHD 2019:
  • A minimum of five attacks (in absolute terms) fulfilling criteria:
  • Duration 4 - 72 hours
  • At least two of the following:
  • unilateral location
  • pulsating character
  • moderate or severe pain intensity
  • aggravation by routine physical activity
  • Presence of nausea/vomiting OR photophobia/phonophobia during headache
  • Ongoing therapy with medication known to affect the gut microbiome:
  • Antibiotics used in the last 8 weeks
  • Proton pump inhibitors used in the last 8 weeks
  • Antidepressants in the last 8 weeks
  • Regular use of laxatives or anti-diarrheal medications
  • Alcohol consumption >14 units per week
  • Pregnancy or breastfeeding
  • Vegan and other selective diets, use of diet replacements (e.g. Huel)
  • Regular consumption of probiotics, prebiotics, fibre supplements or any use of probiotics in 2 months prior enrolment
  • Unwillingness to exclude other probiotic products from diet during the study period

结局指标

主要结局

Stool sample comparison

时间窗: 56 days

Comparison between samples at different taxonomical levels (phylum, family, genus and species) will be performed for the identification of specific bacteria in samples of interest. Accumulative bar charts will be provided for rapid inspection. PCA and clustering will be conducted. Biodiversity Index (Shannon, Simpson, Gini-Simpson or Berger-Parker) will be calculated. Biostatistics will be done in order to detect biomarkers between timepoints of the study.

次要结局

  • Fasting breath samples(56 days)
  • Bowel habit(56 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr Anthony Hobson

Consultant Clinical Scientist

The Functional Gut Clinic

研究点 (2)

Loading locations...

相似试验